alexa Abstract | Synthesis and Antimicrobial Study of Triazolo[3,4-b][1,3,4]Thiadiazole and Triazolo-[3,4-b][1,3,4]Thiadiazine derivatives of Chromeno [4,3-b]pyridin-5-one moiety

Journal of Chemical and Pharmaceutical Research
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Original Articles Open Access

Abstract

The series of new Triazolo[3,4-b][1,3,4]thiadiazole (7a-e) and Triazolo[3,4-b][1,3,4]thiadiazine (8a-e) derivatives of chromeno[4,3-b]pyridin-5-one were successfully synthesized by multistep synthesis of 4-amino-3-Formyl-2-oxo- 2H-chromene. The newly synthesized compounds were well characterized by IR, 1HNMR, 13CNMR, Mass and Elemental analysis. The compounds were evaluated for their antimicrobial activity against three antibacterial species namely Staphylococcus aureus, Escherichia coli and Bacillus cereus and two fungal species namely Candida albicans and Aspergillus clavatus. Most of the compounds show very good antimicrobial inhibition while compared with the standard drug such as Ciprofloxacin and Ketoconazole.

To read the full article Peer-reviewed Article PDF image

Author(s): Ghanshyam R Jadhav Vijay J Medhane Vishwas B Gaikwad Dattatray G Deshmukh Sharad S Gaikwad and Avinash D Bholay

Keywords

Coumarin, Triazolothiadiazole, Triazolothiadiazine, Antimicrobial activity., Chromeno [4,3-b]pyridin-5-one moiety

 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us